N. Tanahashi et al., PLATELET ACTIVATION AND ERYTHROCYTE AGGREGATION RATE IN PATIENTS WITHCEREBRAL INFARCTION, Clinical hemorheology, 16(4), 1996, pp. 497-505
We measured the platelet activation and the rate of erythrocyte aggreg
ation simultaneously employing venous blood from 31 patients with cere
bral infarction during the acute phase (less than 7 days after onset)
and 73 patients with cerebral infarction during the chronic phase (mor
e than 1 month after onset.). The degree of platelet activation was es
timated from the levels of plasma beta-thromboglobulin (BTG), platelet
factor 4 (PF4), and thrombospondin (TSP). The erythrocyte aggregation
rate was examined using the whole-blood erythrocyte aggregometer deve
loped by us (Am. J. Physiol. 251, H1205-H1210, 1986) with concomitant
measurement of the fibrinogen concentration. The mean values of the er
ythrocyte aggregation rate, plasma BTG, PF4, TSP and fibrinogen concen
tration at the acute phase of cerebral infarction were statistically s
ignificantly (P<0.05) higher than those at the chronic phase of cerebr
al infarction or in the control group, Multiple regression analysis re
vealed that fibrinogen, BTG and TSP were main factors contributing to
the enhanced erythrocyte aggregation rate at the acute phase of cerebr
al infarction, but fibrinogen was the sole contributing factor at the
chronic phase of cerebral infarction. We conclude that the platelet ac
tivation, erythrocyte aggregation rate and fibrinogen concentration we
re closely correlated with each other in patients with cerebral infarc
tion during the acute phase.